Back

Anticoagulation after cavotricuspid isthmus-dependent atrial flutter ablation: essential or overused?

19 May 2025 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Interventions for atrial fibrillation in heart failure Clinical HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Helena Santos Moreira

Sao Joao University Hospital Centre, Porto (Portugal)

5 More presentations in this session

Presentation thumbnail
Characterising recurrent atrial fibrillation after catheter ablation: patterns of pulmonary vein reconnection and predictors of complete pulmonary vein isolation
Doctor A. Aguiar Neves (Vila Nova de Gaia, PT)
Abstract Slides Video
Presentation thumbnail
Assessment of heart failure outcomes in long-standing persistent atrial fibrillation patients following sinus rhythm restoration with an implantable cardioverter defibrillator
Doctor N. Kuridze (Tbilisi, GE)
Abstract Slides Video
Presentation thumbnail
Efficacy of conduction system pacing versus right ventricular pacing in post transaortic valve replacement atrioventricular block: a meta-analysis
Doctor M. Co (Taguig, PH)
Abstract Slides Video
Presentation thumbnail
Comparison of conscious sedation and general anesthesia for atrial flutter ablation: patient satisfaction, clinical outcomes and procedural efficiency
Doctor H. Santos Moreira (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Aromatase index is associated with inflammation and prognosis in male patients with cirrhosis
Doctor N. Semerdzieva (Sofia, BG)
Abstract Slides Video

Access the full session

Session thumbnail
Interventions for atrial fibrillation in heart failure

The Event

Event poster

Heart Failure 2025

19 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Outcomes after cavotricuspid isthmus ablation: predictors of new-onset atrial fibrillation and stroke according to anticoagulation strategy
thumbnail
Congress Presentation
Is the risk of ischemic stroke lower in atrial flutter compared to atrial fibrillation?
thumbnail
Congress Presentation
Rethinking anticoagulation: challenges in assessing stroke risk in atrial fibrillation patients with low CHADS-VASc scores

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources